We use cookies for a better user experience. Read our Privacy Policy
I Agree
Particle Therapy Market
Analysts’ Viewpoint on Particle Therapy Market Scenario
The global particle therapy market is expected to be driven by rise in prevalence of cancer, low risk of treatment-induced disorders, and increase in the number of particle therapy centers across the world. The primary goal of the proton therapy is to improve radiation therapy by using proton beams for the treatment of localized tumors and radiosurgery. Particle therapy is a type of radiotherapy. Its beam speed can be adjusted based on the depth of the treatment site, allowing it to deliver a concentrated dose of radiation to the cancer patient. Benefits of the particle therapy in specific clinical situations have been confirmed by rise in the number of trials, and advancements in beam delivery, image guidance, and treatment planning are expected during the forecast period. Moreover, positive clinical results have led to an increase in the number of treatment facilities across the world of which, several are in the planning stage or under construction.
Particle therapy is also known as the radiation therapy that uses streams of protons that are tiny particles with a positive charge to kill tumor cells. Healthcare providers are increasingly making available different types of particle therapy for cancers such as heavy ion therapy and proton therapy (PT). Non-invasive nature and reduced side effects of proton therapy systems are being preferred for the treatment of bladder cancer in patients.
In order to increase patient outcomes, companies in the particle therapy market are turning challenging collaboration projects and concepts into solutions that serve social innovation. Leading research and care institutes are joining forces to advance in innovations for radiotherapy. Technological developments in cyclotron machines are one of the important strategies that are underway for the treatment of cancer patient.
Request a sample to get extensive insights into the Particle Therapy Market
The COVID-19 pandemic has potentially slowed the progress of paradigm-changing innovations in particle that could improve the lives of future generations. Nevertheless, companies in the particle therapy market are adapting to the new normal by continuing care services for high-risk and vulnerable cancer patients.
Cancer care facilities are implementing rigid safety protocols and adaptations for the patients & staff. In order to ensure the adherence to safety protocols, cancer care centers are instituting many precautions that include daily screenings of every staff member, patient, and visitor to the center. In addition, rise of telemedicine and remote patient monitoring would likely become one of the defining influences of the pandemic on the global healthcare industry.
The global particle therapy market is projected to advance at a robust CAGR throughout the assessment period. However, lack of evidence about clinical outcomes, high cost of therapy, and radiobiological uncertainties are hampering its widespread adoption among cancer patients. Hence, companies in the particle therapy market are increasing R&D to overcome technological challenges and increasing efforts to integrate technical developments into particle therapy systems.
Companies in the particle therapy market are conducting research studies to continuously improve the efficiency of proton therapy systems, in terms of technology and delivery technics & cost. Significant developments are being made in terms of conformation of the dose to the target and transport & spatial resolution achievable with pencil beam scanning.
There is a growing demand for proton therapy for the treatment of breast cancer, brain tumor, and pediatric cancer. There is a high prevalence of inflammatory breast cancer, triple negative breast cancer, and invasive ductal carcinoma breast cancer globally.
The proton therapy is also being used in the treatment of patients with benign tumors, tumors near sensitive areas of the brain, and patients who have recurrent brain tumors following treatment.
In addition, advantages of photon-beam radiotherapy are being extended for the treatment of pediatric cancer, since this treatment method is found to limit the radiation exposure to healthy and growing tissue in children, adolescents, and young adults.
An alarmingly high number of cancer cases in India and Italy have compelled healthcare companies in the particle therapy market to invest in state-of-the-art facilities. These facilities are accommodating the hadron therapy, as a part of their care services profile.
The possibility to treat radio-resistant tumors, precision treatment, and suitability for the treatment of brain, skull, and spinal cord is increasing the popularity of hadron therapy among patients. Head, neck, and upper respiratory tract tumors are being treated with the help of the hadron therapy.
Request a custom report on Particle Therapy Market
|
Attribute |
Detail |
|
Market Size Value in 2021 |
US$ 560.3 Mn |
|
Market Forecast Value in 2031 |
US$ 1,267.16 Mn |
|
Growth Rate (CAGR) |
8.6% from Year-to-Year |
|
Forecast Period |
2022–2031 |
|
Quantitative Units |
US$ Mn for Value |
|
Market Analysis |
It includes cross segment analysis at global as well as regional level. Moreover, qualitative analysis includes drivers, restraints, opportunities, key trends, and parent industry overview. |
|
Competition Landscape |
|
|
Format |
Electronic (PDF) + Excel |
|
Market Segmentation |
|
|
Regions Covered |
|
|
Countries Covered |
|
|
Companies Profiled |
|
|
Customization Scope |
Available upon request |
|
Pricing |
Available upon request |
Particle Therapy Market – Segmentation
TMR’s study on the global particle therapy market includes information divided into five segments: therapy, application, service, end-user, and region. Changing industry trends and other market dynamics associated with these segments of the global particle therapy market are discussed in detail.
| Therapy |
|
| Application |
|
| Service |
|
| End-user |
|
| Region |
|
Note: Each of the segments has been analyzed in detail for market trends, recent trends, and developments, drivers, restraints, opportunities, and useful insights.
Interested in this report?
Get a FREE sample now!
*Get Sample Report (PDF) sent to your email within minutes
Particle therapy market was valued at US$ 560.3 Mn in 2021 and expected to exceed US$ 1.2 Bn by 2031
Particle Therapy market is expected to grow at a CAGR of 9% during the forecast period
Increase in number of cancer patients and rise in adoption of particle therapy in clinical trials are projected to drive this market
The particle therapy market in Europe is likely to expand at the fastest CAGR during the forecast period
The proton therapy segment is likely to generate highest revenue in 2031
Varian Medical Systems, Inc. (Siemens Healthineers AG), Hitachi, Ltd., and IBA Worldwide are prominent players in the global market
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary: Global Particle Therapy Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Particle Therapy Market Analysis and Forecast, 2017–2031
4.4.1. Market Revenue Projections (US$ Mn)
5. Key Insights
5.1. Technological Advancements
5.2. Reimbursement Scenario
5.3. Particle Therapy Facilities In Clinical Operation, 2021
5.4. Average Prices, by Region, 2021
5.5. COVID-19 Pandemics Impact on Industry (value chain and short / mid / long term impact)
6. Global Particle Therapy Market Analysis and Forecast, By Therapy
6.1. Introduction & Definition
6.2. Key Findings / Developments
6.3. Market Value Forecast, by Therapy, 2017–2031
6.3.1. Proton Therapy
6.3.2. Heavy Ion Therapy (carbon therapy, He, pion)
6.4. Market Attractiveness Analysis, By Therapy
7. Global Particle Therapy Market Analysis and Forecast, By Application
7.1. Introduction & Definition
7.2. Key Findings / Developments
7.3. Market Value Forecast, by Application, 2017–2031
7.3.1. Pediatric Cancer
7.3.2. Lung Cancer
7.3.3. Bladder Cancer
7.3.4. Brain & Spinal Cord Tumors (BSCT)
7.3.5. Breast Cancer
7.3.6. Gastrointestinal (GI) Cancers
7.3.7. Hepatocellular Carcinoma (HCC)
7.3.8. Head & Neck Cancers (HNC)
7.3.9. Others
7.4. Market Attractiveness Analysis, By Application
8. Global Particle Therapy Market Analysis and Forecast, By Service
8.1. Introduction & Definition
8.2. Key Findings / Developments
8.3. Market Value Forecast, by Service, 2017–2031
8.3.1. Cyclotrons
8.3.2. Synchrotrons
8.3.3. Synchrocyclotrons
8.4. Market Attractiveness Analysis, By Service
9. Global Particle Therapy Market Analysis and Forecast, By End-user
9.1. Introduction & Definition
9.2. Key Findings / Developments
9.3. Market Value Forecast, by End-user, 2017–2031
9.3.1. Hospitals
9.3.2. Academic & Research Centers
9.4. Market Attractiveness Analysis, By End-user
10. Global Particle Therapy Market Analysis and Forecast, By Region
10.1. Key Findings
10.2. Market Value Forecast, by Region
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Rest of the World
10.3. Market Attractiveness Analysis, By Region
11. North America Particle Therapy Market Analysis and Forecast
11.1. Introduction
11.1.1. Key Findings
11.2. Market Value Forecast, by Therapy, 2017–2031
11.2.1. Proton Therapy
11.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
11.3. Market Value Forecast, by Application, 2017–2031
11.3.1. Pediatric Cancer
11.3.2. Lung Cancer
11.3.3. Bladder Cancer
11.3.4. Brain & Spinal Cord Tumors (BSCT)
11.3.5. Breast Cancer
11.3.6. Gastrointestinal (GI) Cancers
11.3.7. Hepatocellular Carcinoma (HCC)
11.3.8. Head & Neck Cancers (HNC)
11.3.9. Others
11.4. Market Value Forecast, by Service, 2017–2031
11.4.1. Cyclotrons
11.4.2. Synchrotrons
11.4.3. Synchrocyclotrons
11.5. Market Value Forecast, by End-user, 2017–2031
11.5.1. Hospitals
11.5.2. Academic & Research Centers
11.6. Market Value Forecast, by Country, 2017–2031
11.6.1. U.S.
11.6.2. Canada
11.7. Market Attractiveness Analysis
11.7.1. By Therapy
11.7.2. By Application
11.7.3. By Service
11.7.4. By End-user
11.7.5. By Country
12. Europe Particle Therapy Market Analysis and Forecast
12.1. Introduction
12.1.1. Key Findings
12.2. Market Value Forecast, by Therapy, 2017–2031
12.2.1. Proton Therapy
12.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
12.3. Market Value Forecast, by Application, 2017–2031
12.3.1. Pediatric Cancer
12.3.2. Lung Cancer
12.3.3. Bladder Cancer
12.3.4. Brain & Spinal Cord Tumors (BSCT)
12.3.5. Breast Cancer
12.3.6. Gastrointestinal (GI) Cancers
12.3.7. Hepatocellular Carcinoma (HCC)
12.3.8. Head & Neck Cancers (HNC)
12.3.9. Others
12.4. Market Value Forecast, by Service, 2017–2031
12.4.1. Cyclotrons
12.4.2. Synchrotrons
12.4.3. Synchrocyclotrons
12.5. Market Value Forecast, by End-user, 2017–2031
12.5.1. Hospitals
12.5.2. Academic & Research Centers
12.6. Market Value Forecast, by Country/Sub-region, 2017–2031
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Market Attractiveness Analysis
12.7.1. By Therapy
12.7.2. By Application
12.7.3. By Service
12.7.4. By End-user
12.7.5. By Country/Sub-region
13. Asia Pacific Particle Therapy Market Analysis and Forecast
13.1. Introduction
13.1.1. Key Findings
13.2. Market Value Forecast, by Therapy, 2017–2031
13.2.1. Proton Therapy
13.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
13.3. Market Value Forecast, by Application, 2017–2031
13.3.1. Pediatric Cancer
13.3.2. Lung Cancer
13.3.3. Bladder Cancer
13.3.4. Brain & Spinal Cord Tumors (BSCT)
13.3.5. Breast Cancer
13.3.6. Gastrointestinal (GI) Cancers
13.3.7. Hepatocellular Carcinoma (HCC)
13.3.8. Head & Neck Cancers (HNC)
13.3.9. Others
13.4. Market Value Forecast, by Service, 2017–2031
13.4.1. Cyclotrons
13.4.2. Synchrotrons
13.4.3. Synchrocyclotrons
13.5. Market Value Forecast, by End-user, 2017–2031
13.5.1. Hospitals
13.5.2. Academic & Research Centers
13.6. Market Value Forecast, by Country/Sub-region, 2017–2031
13.6.1. China
13.6.2. Japan
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Market Attractiveness Analysis
13.7.1. By Therapy
13.7.2. By Application
13.7.3. By Service
13.7.4. By End-user
13.7.5. By Country/Sub-region
14. Rest of the World Particle Therapy Market Analysis and Forecast
14.1. Introduction
14.1.1. Key Findings
14.2. Market Value Forecast, by Therapy, 2017–2031
14.2.1. Proton Therapy
14.2.2. Heavy Ion Therapy (carbon therapy, He, pion)
14.3. Market Value Forecast, by Application, 2017–2031
14.3.1. Pediatric Cancer
14.3.2. Lung Cancer
14.3.3. Bladder Cancer
14.3.4. Brain & Spinal Cord Tumors (BSCT)
14.3.5. Breast Cancer
14.3.6. Gastrointestinal (GI) Cancers
14.3.7. Hepatocellular Carcinoma (HCC)
14.3.8. Head & Neck Cancers (HNC)
14.3.9. Others
14.4. Market Value Forecast, by Service, 2017–2031
14.4.1. Cyclotrons
14.4.2. Synchrotrons
14.4.3. Synchrocyclotrons
14.5. Market Value Forecast, by End-user, 2017–2031
14.5.1. Hospitals
14.5.2. Academic & Research Centers
14.6. Market Attractiveness Analysis
14.6.1. By Therapy
14.6.2. By Application
14.6.3. By Service
14.6.4. By End-user
15. Competition Landscape
15.1. Market Player - Competition Matrix (by tier and size of companies)
15.2. Market Share Analysis, by Company, 2020
15.3. Company Profiles
15.3.1. Advanced Oncotherapy plc
15.3.1.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.1.2. Product Portfolio
15.3.1.3. SWOT Analysis
15.3.1.4. Strategic Overview
15.3.2. Danfysik A/S
15.3.2.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.2.2. Product Portfolio
15.3.2.3. SWOT Analysis
15.3.2.4. Strategic Overview
15.3.3. Hitachi, Ltd.
15.3.3.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.3.2. Product Portfolio
15.3.3.3. SWOT Analysis
15.3.3.4. Strategic Overview
15.3.4. IBA Worldwide
15.3.4.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.4.2. Product Portfolio
15.3.4.3. SWOT Analysis
15.3.4.4. Strategic Overview
15.3.5. Mevion Medical Systems, Inc.
15.3.5.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.5.2. Product Portfolio
15.3.5.3. SWOT Analysis
15.3.5.4. Strategic Overview
15.3.6. Optivus Proton Therapy, Inc.
15.3.6.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.6.2. Product Portfolio
15.3.6.3. SWOT Analysis
15.3.6.4. Strategic Overview
15.3.7. Protom International, Inc.
15.3.7.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.7.2. Product Portfolio
15.3.7.3. SWOT Analysis
15.3.7.4. Strategic Overview
15.3.8. Provision Healthcare
15.3.8.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.8.2. Product Portfolio
15.3.8.3. SWOT Analysis
15.3.8.4. Strategic Overview
15.3.9. Sumitomo Heavy Industries, Ltd.
15.3.9.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.9.2. Product Portfolio
15.3.9.3. SWOT Analysis
15.3.9.4. Strategic Overview
15.3.10. Varian Medical Systems, Inc.
15.3.10.1. Company Overview (HQ, Business Segments, Employee Strength)
15.3.10.2. Product Portfolio
15.3.10.3. SWOT Analysis
15.3.10.4. Strategic Overview
List of Tables
Table 01: Global Particle Therapy Market Value (US$ Mn) Forecast, by Therapy 2017–2031
Table 02: Global Particle Therapy Market Value (US$ Mn) Forecast, by Application, 2017‒2031
Table 03: Global Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017‒2031
Table 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017‒2031
Table 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Region, 2017–2031
Table 06: North America Particle Therapy Market Value (US$ Mn) Forecast, by Country, 2017–2031
Table 07: North America Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 08: North America Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031
Table 09: North America Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 10: North America Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 11: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 12: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 13: Europe Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031
Table 14: Europe Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 15: Europe Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 16: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2031
Table 17: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 18: Asia Pacific Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031
Table 19: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 20: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
Table 21: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Therapy, 2017–2031
Table 22: Rest of the World Particle Therapy Market (US$ Mn) Forecast, by Application, 2017–2031
Table 23: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by Service, 2017–2031
Table 24: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, by End-user, 2017–2031
List of Figures
Figure 01: Global Particle Therapy market Value (US$ Mn) Forecast, 2017–2031
Figure 02: Global Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 03: Global Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 04: Global Particle Therapy Market Value (US$ Mn) Forecast, by Proton Therapy, 2017–2031
Figure 05: Global Particle Therapy Market Value (US$ Mn) Forecast, by Heavy Ion Therapy, 2017–2031
Figure 06: Global Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
Figure 07: Global Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031
Figure 08: Global Particle Therapy Market Value (US$ Mn) Forecast, by Pediatric Cancer, 2017–2031
Figure 09: Global Particle Therapy Market Value (US$ Mn) Forecast, by Lung Cancer, 2017–2031
Figure 10: Global Particle Therapy Market Value (US$ Mn) Forecast, by Bladder Cancer, 2017–2031
Figure 11: Global Particle Therapy Market Value (US$ Mn) Forecast, by Brain &Spinal Cord Tumors, 2017–2031
Figure 12: Global Particle Therapy Market Value (US$ Mn) Forecast, by Breast Cancer, 2017–2031
Figure 13: Global Particle Therapy Market Value (US$ Mn) Forecast, by Gastrointestinal (GI) Cancers, 2017–2031
Figure 14: Global Particle Therapy Market Value (US$ Mn) Forecast, by Hepatocellular Carcinoma (HCC), 2017–2031
Figure 15: Global Particle Therapy Market Value (US$ Mn) Forecast, by Head & Neck Cancers (HNC), 2017–2031
Figure 16: Global Particle Therapy Market Value (US$ Mn) Forecast, by Other Cancers, 2017–2031
Figure 17: Global Particle Therapy Market, by Service, 2021 and 2031
Figure 18: Global Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031
Figure 19: Global Particle Therapy Market Value (US$ Mn) Forecast, by Cyclotrons, 2017–2031
Figure 20: Global Particle Therapy Market Value (US$ Mn) Forecast, by Synchrotrons, 2017–2031
Figure 21: Global Particle Therapy Market Value (US$ Mn) Forecast, by Synchrocyclotrons, 2017–2031
Figure 22: Global Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 23: Global Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 24: Global Particle Therapy Market (US$ Mn), by Hospitals, 2017–2031
Figure 25: Global Particle Therapy Market (US$ Mn), by Academic & Research Institutes, 2017–2031
Figure 26: Global Particle Therapy Market Value Share Analysis, by Region, 2021 and 2031
Figure 27: Global Particle Therapy Market Attractiveness Analysis, by Region, 2022–2031
Figure 28: North America Particle Therapy Market Value (US$ Mn) Forecast, 2017–2031
Figure 29: North America Particle Therapy Market Value Share Analysis, by Country, 2021 and 2031
Figure 30: North America Particle Therapy Market Attractiveness Analysis, by Country, 2022–2031
Figure 31: North America Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 32: North America Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 33: North America Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
Figure 34: North America Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031
Figure 35: North America Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031
Figure 36: North America Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031
Figure 37: North America Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 38: North America Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 39: Europe Particle Therapy Market Value (US$ Mn) Forecast, 2017–2031
Figure 40: Europe Particle Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 41: Europe Particle Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 42: Europe Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 43: Europe Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 44: Europe Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
Figure 45: Europe Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031
Figure 46: Europe Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031
Figure 47: Europe Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031
Figure 48: Europe Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 49: Europe Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 50: Asia Pacific Particle Therapy Market Value (US$ Mn) Forecast, 2017–2031
Figure 51: Asia Pacific Particle Therapy Market Value Share Analysis, by Country/Sub-region, 2021 and 2031
Figure 52: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Country/Sub-region, 2022–2031
Figure 53: Asia Pacific Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 54: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 55: Asia Pacific Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
Figure 56: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031
Figure 57: Asia Pacific Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031
Figure 58: Asia Pacific Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031
Figure 59: Asia Pacific Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 60: Asia Pacific Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Figure 61: Rest of the World Particle Therapy Market Value (US$ Mn) Forecast, 2017–2031
Figure 62: Rest of the World Particle Therapy Market Value Share Analysis, by Therapy, 2021 and 2031
Figure 63: Rest of the World Particle Therapy Market Attractiveness Analysis, by Therapy, 2022–2031
Figure 64: Rest of the World Particle Therapy Market Value Share Analysis, by Application, 2021 and 2031
Figure 65: Rest of the World Particle Therapy Market Attractiveness Analysis, by Application, 2022–2031
Figure 66: Rest of the World Particle Therapy Market Value Share Analysis, by Service, 2021 and 2031
Figure 67: Rest of the World Particle Therapy Market Attractiveness Analysis, by Service, 2022–2031
Figure 68: Rest of the World Particle Therapy Market Value Share Analysis, by End-user, 2021 and 2031
Figure 69: Rest of the World Particle Therapy Market Attractiveness Analysis, by End-user, 2022–2031
Complete the form below and we'll get back to you shortly.
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
